Electronic Prescribing

  • Mical Paul
  • Roberto Cauda
  • Leonard Leibovici


Prescription of antibiotic treatment is complex. While most patients with fever do not require antibiotic treatment, early administration of appropriate antibiotics to patients with certain bacterial infections improves survival. Antibiotic use leads to bacterial resistance. Antibiotics can thus be justified only when truly needed. The narrowest spectrum antibiotic should be used to prevent resistance development to the more advanced antibiotics. However, the pathogen(s) causing infections become known only after 24–72 hours of infection onset and at many times are not isolated at all.


Antibiotic Treatment Decision Support System Antibiotic Prescription Clinical Decision Support System Computerize Physician Order Entry 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31: 2742–51.CrossRefPubMedGoogle Scholar
  2. 2.
    Hanon FX, Monnet DL, Sorensen TL, Molbak K, Pedersen G, Schonheyder H. Survival of patients with bacteraemia in relation to initial empirical antimicrobial treatment. Scand J Infect Dis 2002; 34: 520–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115: 529–35.CrossRefPubMedGoogle Scholar
  4. 4.
    Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146–55.CrossRefPubMedGoogle Scholar
  5. 5.
    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49: 760–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244: 379–86.CrossRefPubMedGoogle Scholar
  7. 7.
    Pazos Anon R, Fernandez Rodriguez R, Tinajas A, Nanin C, Bustillo M, Paz I, Barreiro R, Gayoso Diz P. [Antimicrobial susceptibility of the bloodstream infections: A study in a nonteaching hospital]. An Med Intern 2004; 21: 483–7.Google Scholar
  8. 8.
    Valles J, Rello J, Ochagavia A, Garnacho J, Alcala MA. Community-acquired bloodstream infection in critically ill adult patients: Impact of shock and inappropriate antibiotic therapy on survival. Chest 2003; 123: 1615–24.CrossRefPubMedGoogle Scholar
  9. 9.
    Zaidi M, Sifuentes-Osornio J, Rolon AL, Vazquez G, Rosado R, Sanchez M, Calva JJ, de Leon-Rosales SP. Inadequate therapy and antibiotic resistance. Risk factors for mortality in the intensive care unit. Arch Med Res 2002; 33: 290–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Pedersen G, Schonheyder HC, Sorensen HT. Source of infection and other factors associated with case fatality in community-acquired bacteremia—A Danish population-based cohort study from 1992 to 1997. Clin Microbiol Infect 2003; 9: 793–802.CrossRefPubMedGoogle Scholar
  11. 11.
    Leibovici L, Wysenbeek AJ. Single-dose antibiotic treatment for symptomatic urinary tract infections in women: A meta-analysis of randomized trials. Q J Med 1991; 78: 43–57.PubMedGoogle Scholar
  12. 12.
    Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643–54.CrossRefPubMedGoogle Scholar
  13. 13.
    Paul M, Soares-Weiser K, Grozinsky S, Leibovici L. Beta-lactam versus beta-lactamaminoglycoside combination therapy in cancer patients with neutropaenia. Cochrane Database Syst Rev 2003; CD003038.Google Scholar
  14. 14.
    Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: A systematic review. Arch Intern Med 2003; 163: 1409 –16.CrossRefPubMedGoogle Scholar
  15. 15.
    Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, Kimmel SE, Strom BL. Role of computerized physician order entry systems in facilitating medication errors. JAMA 2005; 293: 1197 –203.CrossRefPubMedGoogle Scholar
  16. 16.
    Hunt DL, Haynes RB, Hanna SE, Smith K. Effects of computer-based clinical decision support systems on physician performance and patient outcomes: A systematic review. JAMA 1998; 280: 1339–46.CrossRefPubMedGoogle Scholar
  17. 17.
    Garg AX, Adhikari NK, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, Sam J, Haynes RB. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: A systematic review. JAMA 2005; 293: 1223–38.CrossRefPubMedGoogle Scholar
  18. 18.
    Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: A systematic review of trials to identify features critical to success. Br Med J 2005; 330: 765.CrossRefGoogle Scholar
  19. 19.
    Ramsay C, Brown E, Hartman G, Davey P. Room for improvement: A systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. J Antimicrob Chemother 2003; 52: 764–71.CrossRefPubMedGoogle Scholar
  20. 20.
    Yu VL, Fagan LM, Wraith SM, Clancey WJ, Scott AC, Hannigan J, Blum RL, Buchanan BG, Cohen SN. Antimicrobial selection by a computer. A blinded evaluation by infectious diseases experts. JAMA 1979; 242: 1279–82.CrossRefPubMedGoogle Scholar
  21. 21.
    Wraith SM, Aikins JS, Buchanan BG, Clancey WJ, Davis R, Fagan LM, Hannigan JF, Scott AC, Shortliffe EH, van Melle WJ, Yu VL, Axline SG, Cohen SN. Computerized consultation system for selection of antimicrobial therapy. Am J Hosp Pharm 1976; 33: 1304 –8.PubMedGoogle Scholar
  22. 22.
    Yu VL, Buchanan BG, Shortliffe EH, Wraith SM, Davis R, Scott AC, Cohen SN. Evaluating the performance of a computer-based consultant. Comput Programs Biomed 1979; 9: 95 –102.CrossRefPubMedGoogle Scholar
  23. 23.
    Leibovici L, Gitelman V, Yehezkelli Y, Poznanski O, Milo G, Paul M, Ein-Dor P. Improving empirical antibiotic treatment: Prospective, nonintervention testing of a decision support system. J Intern Med 1997; 242: 395–400.CrossRefPubMedGoogle Scholar
  24. 24.
    Mullett CJ, Evans RS, Christenson JC, Dean JM. Development and impact of a computerized pediatric antiinfective decision support program. Pediatrics 2001; 108: E75.CrossRefPubMedGoogle Scholar
  25. 25.
    Antibiotic-related ADEs plummet and pharmacy costs shrink with computer-aided decision support. Clin Resour Manag 2000; 1: 151–3.Google Scholar
  26. 26.
    Burke JP, Pestotnik SL. Antibiotic use and microbial resistance in intensive care units: Impact of computer-assisted decision support. J Chemother 1999; 11: 530–5.PubMedGoogle Scholar
  27. 27.
    Evans RS, Pestotnik SL, Classen DC, Burke JP. Evaluation of a computer-assisted antibiotic-dose monitor. Ann Pharmacother 1999; 33: 1026 –31.CrossRefPubMedGoogle Scholar
  28. 28.
    Warner H Jr, Reimer L, Suvinier D, Li L, Nelson M. Modeling empiric antibiotic therapy evaluation of QID. Proc AMIA Symp 1999; 440–4.Google Scholar
  29. 29.
    Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF Jr, Lloyd JF, Burke JP. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 1998; 338: 232 –8.CrossRefPubMedGoogle Scholar
  30. 30.
    Warner H Jr, Blue SR, Sorenson D, Reimer L, Li L, Nelson M, Barton M, Warner H. New computer-based tools for empiric antibiotic decision support. Proc AMIA Annu Fall Symp 1997; 238–42.Google Scholar
  31. 31.
    Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: Clinical and financial outcomes. Ann Intern Med 1996; 124: 884 –90.PubMedGoogle Scholar
  32. 32.
    Evans RS, Classen DC, Pestotnik SL, Clemmer TP, Weaver LK, Burke JP. A decision support tool for antibiotic therapy. Proc Annu Symp Comput Appl Med Care 1995; 651–5.Google Scholar
  33. 33.
    Evans RS, Classen DC, Pestotnik SL, Lundsgaarde HP, Burke JP. Improving empiric antibiotic selection using computer decision support. Arch Intern Med 1994; 154: 878 –84.CrossRefPubMedGoogle Scholar
  34. 34.
    Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP. Preventing adverse drug events in hospitalized patients. Ann Pharmacother 1994; 28: 523–7.PubMedGoogle Scholar
  35. 35.
    Evans RS, Pestotnik SL. Applications of medical informatics in antibiotic therapy. Adv Exp Med Biol 1994; 349: 87–96.PubMedGoogle Scholar
  36. 36.
    Evans RS, Pestotnik SL, Classen DC, Burke JP. Development of an automated antibiotic consultant. MD Comput 1993; 10: 17–22.PubMedGoogle Scholar
  37. 37.
    Evans RS. The HELP system: A review of clinical applications in infectious diseases and antibiotic use. MD Comput 1991; 8: 282–8,315.PubMedGoogle Scholar
  38. 38.
    Burke JP, Classen DC, Pestotnik SL, Evans RS, Stevens LE. The HELP system and its application to infection control. J Hosp Infect 1991; 18 Suppl A: 424–431.CrossRefPubMedGoogle Scholar
  39. 39.
    Evans RS, Pestotnik SL, Burke JP, Gardner RM, Larsen RA, Classen DC. Reducing the duration of prophylactic antibiotic use through computer monitoring of surgical patients. DICP 1990; 24: 351–4.PubMedGoogle Scholar
  40. 40.
    Larsen RA, Evans RS, Burke JP, Pestotnik SL, Gardner RM, Classen DC. Improved perioperative antibiotic use and reduced surgical wound infections through use of computer decision analysis. Infect Control Hosp Epidemiol 1989; 10: 316–20.CrossRefPubMedGoogle Scholar
  41. 41.
    Gierl L, Steffen D, Ihracky D, Schmidt R. Methods, architecture, evaluation and usability of a case-based antibiotics advisor. Comput Methods Programs Biomed 2003; 72: 139–54.CrossRefPubMedGoogle Scholar
  42. 42.
    Schmidt R, Gierl L. Case-based reasoning for antibiotics therapy advice: An investigation of retrieval algorithms and prototypes. Artif Intell Med 2001; 23: 171 –86.CrossRefPubMedGoogle Scholar
  43. 43.
    Mullett CJ, Thomas JG, Smith CL, Sarwari AR, Khakoo RA. Computerized antimicrobial decision support: An offline evaluation of a database-driven empiric antimicrobial guidance program in hospitalized patients with a bloodstream infection. Int J Med Inform 2004; 73: 455–60.CrossRefPubMedGoogle Scholar
  44. 44.
    Samore MH, Bateman K, Alder SC, Hannah E, Donnelly S, Stoddard GJ, Haddadin B, Rubin MA, Williamson J, Stults B, Rupper R, Stevenson K. Clinical decision support and appropriateness of antimicrobial prescribing: A randomized trial. JAMA 2005; 294: 2305–14.CrossRefPubMedGoogle Scholar
  45. 45.
    Madaras-Kelly KJ, Hannah EL, Bateman K, Samore MH. Experience with a clinical decision support system in community pharmacies to recommend narrow-spectrum antimicrobials, nonantimicrobial prescriptions, and OTC products to decrease broad-spectrum antimicrobial use. J Manag Care Pharm 2006; 12: 390–7.PubMedGoogle Scholar
  46. 46.
    Rubin MA, Bateman K, Donnelly S, Stoddard GJ, Stevenson K, Gardner RM, Samore MH. Use of a personal digital assistant for managing antibiotic prescribing for outpatient respiratory tract infections in rural communities. J Am Med Inform Assoc 2006; 13: 627 –34.CrossRefPubMedGoogle Scholar
  47. 47.
    Thursky KA, Buising KL, Bak N, Macgregor L, Street AC, Macintyre CR, Presneill JJ, Cade JF, Brown GV. Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit. Int J Qual Health Care 2006; 18: 224–31.CrossRefPubMedGoogle Scholar
  48. 48.
    Thursky KA, Mahemoff M. User-centered design techniques for a computerised antibiotic decision support system in an intensive care unit. Int J Med Inform 2006;Google Scholar
  49. 49.
    Sarubbi FA Jr, Hull JH. Amikacin serum concentrations: Prediction of levels and dosage guidelines. Ann Intern Med 1978; 89: 612–8.PubMedGoogle Scholar
  50. 50.
    de Repentigny L, Dumont L, Le Lorier J, Morisset R, Larochelle P, Courchesne Y. Gentamicin: Use of a programmable calculator to determine dosages from pharmacokinetic data for individual patients. Can Med Assoc J 1981; 124: 1459–63.PubMedGoogle Scholar
  51. 51.
    Begg EJ, Atkinson HC, Jeffery GM, Taylor NW. Individualised aminoglycoside dosage based on pharmacokinetic analysis is superior to dosage based on physician intuition at achieving target plasma drug concentrations. Br J Clin Pharmacol 1989; 28: 137–41.PubMedGoogle Scholar
  52. 52.
    Hickling K, Begg E, Moore ML. A prospective randomised trial comparing individualised pharmacokinetic dosage prediction for aminoglycosides with prediction based on estimated creatinine clearance in critically ill patients. Intensive Care Med 1989; 15: 233–7.CrossRefPubMedGoogle Scholar
  53. 53.
    Burton ME, Ash CL, Hill DP Jr, Handy T, Shepherd MD, Vasko MR. A controlled trial of the cost benefit of computerized bayesian aminoglycoside administration. Clin Pharmacol Ther 1991; 49: 685–94.PubMedCrossRefGoogle Scholar
  54. 54.
    Lenert LA, Klostermann H, Coleman RW, Lurie J, Blaschke TF. Practical computer-assisted dosing for aminoglycoside antibiotics. Antimicrob Agents Chemother 1992; 36: 1230–5.PubMedGoogle Scholar
  55. 55.
    Lenert LA, Lurie J, Sheiner LB, Coleman R, Klostermann H, Blaschke TF. Advanced computer programs for drug dosing that combine pharmacokinetic and symbolic modeling of patients. Comput Biomed Res 1992; 25: 29–42.CrossRefPubMedGoogle Scholar
  56. 56.
    Hulgan T, Rosenbloom ST, Hargrove F, Talbert DA, Arbogast PG, Bansal P, Miller RA, Kernodle DS. Oral quinolones in hospitalized patients: An evaluation of a computerized decision support intervention. J Intern Med 2004; 256: 349–57.CrossRefPubMedGoogle Scholar
  57. 57.
    McGregor JC, Weekes E, Forrest GN, Standiford HC, Perencevich EN, Furuno JP,Harris AD. Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: A randomized controlled trial. J Am Med Inform Assoc 2006; 13: 378–384.CrossRefPubMedGoogle Scholar
  58. 58.
    Lucas PJ, de Bruijn NC, Schurink K, Hoepelman A. A probabilistic and decision-theoretic approach to the management of infectious disease at the ICU. Artif Intell Med 2000; 19: 251–79.CrossRefPubMedGoogle Scholar
  59. 59.
    Schurink CA, Lucas PJ, Hoepelman IM, Bonten MJ. Computer-assisted decision support for the diagnosis and treatment of infectious diseases in intensive care units. Lancet Infect Dis 2005; 5: 305–12.CrossRefPubMedGoogle Scholar
  60. 60.
    Kristensen B, Andreassen S, Leibovici L, Riekehr C, Kjaer AG, Schonheyder HC. Empirical treatment of bacteraemic urinary tract infection. Evaluation of a decision support system. Dan Med Bull 1999; 46: 349–53.PubMedGoogle Scholar
  61. 61.
    Andreassen S, Leibovici L, Paul M, Nielsen A, Zalounina A, Kristensen L, Falborg K, Kristensen B, Frank U, Schonheyder H. A probabilistic network for fusion of data and knowledge in clinical microbiology, in Husmeier D, Dybowski R, Roberts S (eds): Probabilistic Modeling in Bioinformatics and Medical Informatics. London, Springer-Verlag, 2004, pp 451–72.Google Scholar
  62. 62.
    Andreassen S, Riekehr C, Kristensen B, Schonheyder HC, Leibovici L. Using probabilistic and decision-theoretic methods in treatment and prognosis modeling. Artif Intell Med 1999; 15: 121–34.CrossRefPubMedGoogle Scholar
  63. 63.
    Leibovici L, Fishman M, Schonheyder HC, Riekehr C, Kristensen B, Shraga I, Andreassen S. A causal probabilistic network for optimal treatment of bacterial infections. IEEE Trans Knowledge Data Eng 2000; 12: 517–28.CrossRefGoogle Scholar
  64. 64.
    Paul M, Andreassen S, Nielsen AD, Tacconelli E, Almanasreh N, Fraser A, Yahav D, Ram R, Leibovici L. Prediction of bacteremia using TREAT, a computerized decision-support system. Clin Infect Dis 2006; 42: 1274–82.CrossRefPubMedGoogle Scholar
  65. 65.
    Paul M, Andreassen S, Tacconelli E, Nielsen AD, Almanasreh N, Frank U, Cauda R, Leibovici L. Improving empirical antibiotic treatment using TREAT, a computerized decision support system: Cluster randomized trial. J Antimicrob Chemother 2006;58: 1238–45CrossRefPubMedGoogle Scholar
  66. 66.
    Frank U, Almanasreh N, Nielsen A, Andreassen S, Tacconelli E, Cauda R, Paul M, Leibovici L. TREAT: An electronic consultant for the clinical microbiologist, in 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2004, American Society for Microbiology.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Mical Paul
    • 1
    • 2
  • Roberto Cauda
    • 3
  • Leonard Leibovici
    • 1
    • 2
  1. 1.Department of Medicine E, Rabin Medical CenterBeilinson HospitalPetah TiqwaIsrael
  2. 2.Sackler Faculty of MedicineTel Aviv UniversityRamat AvivIsrael
  3. 3.Department of Infectious Disease, Gemelli HospitalUniversità Cattolica del Sacro Cuore Medical SchoolRomeItaly

Personalised recommendations